ENRICH clinical trial for untreated mantle cell lymphoma

"Prof. Simon Rule from Derriford Hospital, Plymouth, UK, talks about the ENRICH clinical trial, whihc is looking at the use of ibrutinib and rituximab in newly diagnosed mantle cell lymphoma patients. The current standard of care for these patients would be rituximab plus CHOP or bendamustine. Prof. Rule gives an overview of the trial and the treatment the pantients would receive once they've been assigned to one of the trial arms.
Recorded at the American Society of Hematology (ASH) 2015 Annual Meeting, in Orlando, FL."

—

To see other videos like this or obtain more information please visit http://www.patientpower.eu/
Follow us on Twitter at https://twitter.com/patientpowereu
Like on Facebook at https://www.fb.com/patientpower.europe

Видео ENRICH clinical trial for untreated mantle cell lymphoma канала Patient Power Europe